March 2010 Briefing - RheumatologyLast Updated: April 01, 2010.
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for March 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Knee Osteoarthritis Patients Often Rely on Self-Help
WEDNESDAY, March 31 (HealthDay News) -- Most patients newly diagnosed with knee osteoarthritis seek medical care, but they also institute lifestyle changes -- often without a physician's advice -- which improve their pain and function levels, according to a study in the April issue of Arthritis Care & Research.
Like Men, Uric Acid Levels Linked to Gout in Women
TUESDAY, March 30 (HealthDay News) -- Increasing levels of uric acid are associated with a higher risk of gout in women, although the magnitude of the association is not as great as that seen in men, according to a study in the April issue of Arthritis & Rheumatism.
Two Approaches, Similar Improvement in Back Pain
MONDAY, March 22 (HealthDay News) -- For individuals with chronic low back pain, a multidisciplinary group rehabilitation program and an individual therapist-assisted back strengthening program are associated with similar long-term improvements in pain and disability, according to research published in the March 1 issue of Spine.
FDA Says High-Dose Simvastatin Ups Myopathy Risk
FRIDAY, March 19 (HealthDay News) -- On March 19, the U.S. Food and Drug Administration notified patients and health care professionals about the potential increased risk of myopathy related to simvastatin (Zocor) 80 mg.
Integrated Care Program Beneficial in Low Back Pain
WEDNESDAY, March 17 (HealthDay News) -- In patients with chronic low back pain, an integrated care program that combines a patient-directed and workplace-directed intervention may significantly reduce disability in private and working life, according to a study published online March 16 in BMJ.
SSRIs Show Anti-Inflammatory Benefit in RA Models
FRIDAY, March 12 (HealthDay News) -- Fluoxetine and citalopram show an anti-inflammatory benefit in rheumatoid arthritis (RA) in laboratory experiments, with findings pointing toward endosomal Toll-like receptors (TLRs) as a target for therapy in the disease, according to research published in the March issue of Arthritis & Rheumatism.
Lipoprotein Autoantibodies Higher in More Active Lupus
FRIDAY, March 12 (HealthDay News) -- In patients with systemic lupus erythematosus (SLE), those with persistently high disease activity have higher levels of anti-apolipoprotein A-I (anti-Apo A-I) and anti-high-density lipoprotein (anti-HDL) than those with low disease activity, according to research published in the March issue of Arthritis & Rheumatism.
MRI Shows Benefit in Identifying Types of Arthritis
THURSDAY, March 11 (HealthDay News) -- Patients with rheumatoid and psoriatic arthritis undergoing magnetic resonance imaging (MRI) show differences in synovial enhancement 15 minutes after contrast injection, suggesting that this method may be helpful in differentiating between the diseases, according to research published in the March issue of the American Journal of Roentgenology.
Arthritis Prevalence Is Higher in U.S. Than in Canada
WEDNESDAY, March 3 (HealthDay News) -- Arthritis is significantly more prevalent in the United States than in Canada, especially in American women, according to a study published in the March issue of Arthritis Care & Research. Authors of the study postulate increase may be due to higher rates of obesity and physical inactivity.
|Previous: March 2010 Briefing - Pulmonology||Next: March 2010 Briefing - Surgery|
Reader comments on this article are listed below. Review our comments policy.